Mahmoud S Alghamri
6PUBLICATIONS
52CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy.Brandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb
|Sep 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy.Mahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari
|Jul 12, 2021
A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1.Diana Shah, Andrea Comba, Syed M Faisal
|Jul 10, 2020
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.Mahmoud S Alghamri, Rohit Thalla, Ruthvik P Avvari
|May 14, 2020
Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development.Maria B Garcia-Fabiani, Maria Ventosa, Andrea Comba
|Feb 15, 2019
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.Felipe J Núñez, Flor M Mendez, Padma Kadiyala
Pageof 1
Frequent Collaborators
6 joint publications
Pedro R Lowenstein
3 joint publications
Maria G Castro
3 joint publications
Stephen Carney
3 joint publications
Maria G Castro
2 joint publications
Syed Mohd Faisal
2 joint publications
Padma Kadiyala
2 joint publications
Peter J Ulintz
2 joint publications
Andrea Comba
2 joint publications
María Belén Garcia-Fabiani
2 joint publications
Costas A Lyssiotis
